跳转至内容
Merck
  • Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury.

Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury.

Heliyon (2020-06-25)
Sarah Franco, Amelia Stranz, Fiona Ljumani, Go Urabe, Mirnal Chaudhary, Danielle Stewart, Vijaya Satish Pilli, Matthew Kelly, Dai Yamanouchi, K Craig Kent, Bo Liu
摘要

Accelerated smooth muscle cell (SMC) proliferation is the primary cause of intimal hyperplasia (IH) following vascular interventions. Forkhead Box M1 (FOXM1) is considered a proliferation-associated transcription factor. However, the presence and role of FOXM1 in IH following vascular injury have not been determined. We examined the expression of FOXM1 in balloon-injured rat carotid arteries and investigated the effect of FOXM1 inhibition in SMCs and on the development of IH. FOXM1 was detected by immunofluorescent staining in balloon-injured rat carotid arteries where we observed an upregulation at day 7, 14, and 28 compared to uninjured controls. Immunofluorescence staining revealed FOXM1 coincided with proliferating cell nuclear antigen (PCNA). FOXM1 was also detectable in human carotid plaque samples. Western blot showed an upregulation of FOXM1 protein in serum-stimulated SMCs. Inhibition of FOXM1 using siRNA or chemical inhibition led to the induction of apoptosis as measured by flow cytometry and western blot for cleaved caspase 3. Perturbations in survival signaling were measured by western blot following FOXM1 inhibition, which showed a decrease in phosphorylated AKT and β-catenin. The chemical inhibitor thiostrepton was delivered by intraperitoneal injection in rats that underwent balloon injury and led to reduced intimal thickening compared to DMSO controls. FOXM1 is an important molecular mediator of IH that contributes to the proliferation and survival of SMCs following vascular injury.

材料
货号
品牌
产品描述

Sigma-Aldrich
FDI-6, ≥98% (HPLC)